Cipla Limited Stock/Share live NSE/BSE price today

Live Cipla Limited Share Price Chart

NSE BSE

Cipla Limited Share Performance

Today's Low		Today's High
1,432.55 1,432.70		1,458.20 1458.00

52 Week Low		52 Week High
1,312.00 (31-Jan-2024) 1,312.70 (31-Jan-2024)		1,702.05 (09-Oct-2024) 1,702.00 (09-Oct-2024)

Open: 1,432.55 1,439.20

Previous Close: 1,439.40 1,439.30

Volume: 10.71

Total Traded value: 155.33 (Lakhs)

Upper circuit: 1,583.30 1,457.75

Lower circuit: 1,295.50 1,192.75

Cipla Limited Share Market Depth

Buy Order Quantity		Sell Order Quantity
0		160

Bid Price	Quantity
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	--

Ask Price	Quantity
1,451.15	160.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	160

Cipla Limited Share Fundamentals

Market Cap:	1,172.57 Cr
PE Ratio (TTM):	26.50
PB Ratio:	3.99
Industry P/E:	25.07
Debt to Equity:	-

ROE:	15.06
EPS (TTM):	54.32
Book Value:	317.62
Face Value:	2.00

Cipla Limited Stock Financials

	Sep, 2023	Jun, 2023	Mar, 2023	Dec, 2022	Sep, 2022
Revenue	4,664.72 Cr	4,318.19 Cr	3,893.74 Cr	3,899.45 Cr	4,151.27 Cr
Profit	1,029.69 Cr	895.02 Cr	355.49 Cr	678.52 Cr	720.30 Cr
Expense	3,473.21 Cr	3,249.76 Cr	3,266.00 Cr	3,098.15 Cr	3,273.73 Cr
Comprehensive income	1,001.44 Cr	916.14 Cr	399.21 Cr	677.80 Cr	692.81 Cr
EPS	12.75	11.08	4.40	8.40	8.92

Cipla Limited, along with its subsidiaries, is a leading pharmaceutical company that manufactures and markets pharmaceutical products in India, the United States, South Africa, and globally. The company specializes in producing active pharmaceutical ingredients and formulations in various therapeutic areas, including cardiovascular diseases, diabetes, respiratory disorders, infectious diseases, and many others. Additionally, Cipla Limited offers a range of respiratory products, such as inhalers, nasal sprays, injectables, and biosimilars.

Cipla Limited has established strategic partnerships and licensing agreements with renowned pharmaceutical companies like Merck & Co., Inc., Eli Lilly and Company, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited. These collaborations enable Cipla Limited to manufacture and distribute innovative drugs, such as Molnupiravir, an investigational oral antiviral drug, and baricitinib, a drug used for Covid-19 treatment.

With a rich history dating back to 1935, Cipla Limited is headquartered in Mumbai, India, and continues to be a pioneer in the pharmaceutical industry, committed to improving global healthcare.

Company name	Listing date	Industry	NSE symbol BSE symbol
Cipla Limited	Feb, 1995 Jul, 1983	Pharmaceuticals Pharmaceuticals	CIPLA CIPLA

Cipla Limited Stock Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022

Promoters

33.47%
Public

66.53%
Shares held by Employee Trusts

0.00%
Promoters

33.47%
Public

66.53%
Shares held by Employee Trusts

0.00%
Promoters

33.55%
Public

66.45%
Shares held by Employee Trusts

0.00%
Promoters

33.61%
Public

66.39%
Shares held by Employee Trusts

0.00%
Promoters

33.61%
Public

66.39%
Shares held by Employee Trusts

0.00%

Promoters
	33.47%

Public
	66.53%

Shares held by Employee Trusts
	0.00%

Promoters
	33.47%

Public
	66.53%

Shares held by Employee Trusts
	0.00%

Promoters
	33.55%

Public
	66.45%

Shares held by Employee Trusts
	0.00%

Promoters
	33.61%

Public
	66.39%

Shares held by Employee Trusts
	0.00%

Promoters
	33.61%

Public
	66.39%

Shares held by Employee Trusts
	0.00%

Cipla Limited Share FAQ's

What is the range of today's stock performance for Cipla Limited?

Today's stock performance witnessed a fluctuation from a minimum of 1,432.55 on the NSE (National Stock Exchange) to a maximum of 1,458.20. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,432.70 to a high of 1,458.00.

What are the 52-week low and high values for Cipla Limited?

The stock's performance over the past 52 weeks reveals a low of 1,312.00 (occurred on 31-Jan-2024) and a high of 1,702.05 (achieved on 09-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,312.70 (on 31-Jan-2024), and the 52-week high is 1,702.00 (on 09-Oct-2024).

What was the opening and previous closing prices for Cipla Limited?

The stock's performance over the past 52 weeks reveals a low of 1,312.00 (occurred on 31-Jan-2024) and a high of 1,702.05 (achieved on 09-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,312.70 (on 31-Jan-2024), and the 52-week high is 1,702.00 (on 09-Oct-2024).

What is the total volume and traded value for Cipla Limited for the day?

The total volume is 11, and the total traded value is 155.33 ( Lakhs).

What are the upper and lower circuit limits for Cipla Limited?

The upper circuit limit is 1,583.30, and the lower circuit limit is 1,295.50.

What is the market cap and PE ratio for Cipla Limited?

The market cap is 1,172.57 Cr, and the PE ratio (TTM) is 25.92.

What is the PB ratio, industry P/E, and debt to equity ratio for Cipla Limited?

The PB ratio is 4.57, industry P/E is 25.07 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Cipla Limited?

ROE is 15.06, EPS is 54.32, book value is 317.62

What are the revenue and profit figures for the latest quarter and previous quarters for Cipla Limited?

In Sep 2023, Revenue is 46647200000.00, and Profit is 10296900000.00. In Jun 2023, Revenue is 43181900000.00, and Profit is 8950200000.00.

When was Cipla Limited listed, and what industry does it belong to?

The company, Cipla Limited, was listed in Feb 1995 and belongs to the Pharmaceuticals industry. Its NSE symbol is CIPLA.

What is the current shareholding pattern of the Cipla Limited?

As of latest available update, promoters hold 33.47%, the public holds 66.53%, and Employee Trusts holds 0.00.

Search

Cipla Limited